Search research articles
Contact Us
Filters
Showing results (131-140 of 217) with videos related to
Page
of 22
Sort By:
Journal of Neuro-Oncology
|
October 23, 2012
A phase II study of conventional radiation therapy and thalidomide for supratentorial, newly-diagnosed glioblastoma (RTOG 9806)
Brian M Alexander, Meihua Wang, W K Alfred Yung, et al.
Cancer
|
April 10, 2004
Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma: a North American Brain Tumor Consortium Trial
Susan M Chang, Michael D Prados, W K Alfred Yung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 14, 2003
Phase II evaluation of temozolomide and 13-cis-retinoic acid for the treatment of recurrent and progressive malignant glioma: a North American Brain Tumor Consortium study
Kurt A Jaeckle, Kenneth R Hess, W K Alfred Yung, et al.
Plos One
|
May 16, 2014
Delta-24-RGD oncolytic adenovirus elicits anti-glioma immunity in an immunocompetent mouse model
Hong Jiang, Karen Clise-Dwyer, Kathryn E Ruisaard, et al.
Neoplasia (New York, N.Y.)
|
June 23, 2006
Sustained angiopoietin-2 expression disrupts vessel formation and inhibits glioma growth
Ok-Hee Lee, Juan Fueyo, Jing Xu, et al.
The Journal of Biological Chemistry
|
December 13, 2006
Mitogen-activated protein kinase kinase-4 promotes cell survival by decreasing PTEN expression through an NF kappa B-dependent pathway
Dianren Xia, Harish Srinivas, Young-Ho Ahn, et al.
Journal of Neuro-Oncology
|
July 24, 2010
Combination of 6-thioguanine, capecitabine, and celecoxib with temozolomide or lomustine for recurrent high-grade glioma
Tobias Walbert, Mark R Gilbert, Morris D Groves, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 13, 2003
Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas
Victor A Levin, Kenneth R Hess, Ali Choucair, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 7, 2023
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
Henry S Friedman, Michael D Prados, Patrick Y Wen, et al.
Cancer Chemotherapy and Pharmacology
|
March 7, 2012
Phase I study of AEE788, a novel multitarget inhibitor of ErbB- and VEGF-receptor-family tyrosine kinases, in recurrent glioblastoma patients
David A Reardon, Charles A Conrad, Timothy Cloughesy, et al.
Page
of 22
Search research articles
Search
Showing results (131-140 of 217) with videos related to
Sort By:
Page
of 22
Journal of Neuro-Oncology
|
October 23, 2012
A phase II study of conventional radiation therapy and thalidomide for supratentorial, newly-diagnosed glioblastoma (RTOG 9806)
Brian M Alexander, Meihua Wang, W K Alfred Yung, et al.
Cancer
|
April 10, 2004
Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma: a North American Brain Tumor Consortium Trial
Susan M Chang, Michael D Prados, W K Alfred Yung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 14, 2003
Phase II evaluation of temozolomide and 13-cis-retinoic acid for the treatment of recurrent and progressive malignant glioma: a North American Brain Tumor Consortium study
Kurt A Jaeckle, Kenneth R Hess, W K Alfred Yung, et al.
Plos One
|
May 16, 2014
Delta-24-RGD oncolytic adenovirus elicits anti-glioma immunity in an immunocompetent mouse model
Hong Jiang, Karen Clise-Dwyer, Kathryn E Ruisaard, et al.
Neoplasia (New York, N.Y.)
|
June 23, 2006
Sustained angiopoietin-2 expression disrupts vessel formation and inhibits glioma growth
Ok-Hee Lee, Juan Fueyo, Jing Xu, et al.
The Journal of Biological Chemistry
|
December 13, 2006
Mitogen-activated protein kinase kinase-4 promotes cell survival by decreasing PTEN expression through an NF kappa B-dependent pathway
Dianren Xia, Harish Srinivas, Young-Ho Ahn, et al.
Journal of Neuro-Oncology
|
July 24, 2010
Combination of 6-thioguanine, capecitabine, and celecoxib with temozolomide or lomustine for recurrent high-grade glioma
Tobias Walbert, Mark R Gilbert, Morris D Groves, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 13, 2003
Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas
Victor A Levin, Kenneth R Hess, Ali Choucair, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 7, 2023
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
Henry S Friedman, Michael D Prados, Patrick Y Wen, et al.
Cancer Chemotherapy and Pharmacology
|
March 7, 2012
Phase I study of AEE788, a novel multitarget inhibitor of ErbB- and VEGF-receptor-family tyrosine kinases, in recurrent glioblastoma patients
David A Reardon, Charles A Conrad, Timothy Cloughesy, et al.
Page
of 22